fda warning letter hims compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Takes Aim at Hims

Eating Disorders When Eating Disorder Prevention Meets Corporate Profit: Navigating Complex Waters A call for broader dialogue in eating disorder treatment, exploring how narrative control affects patient care and professional growth

Improved insulin sensitivity reduces the inflammatory burden on blood vessels, and reduced triglycerides lower the atherogenic lipid profile

Theres also real-world evidence, which is taken from observational studies of people prescribed these medications in everyday clinical practice

Please be aware that your doctor may be contacted by one of our team members or by the processing pharmacy in order to verify the prescription

QUALITY & GUARANTEE Glutathione pills do not contain harmful substances